Anti-Human PSCA Antibody (SAA0474), FITC

Catalog No.

FHA73511

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Conjugation

FITC

Target

Prostate stem cell antigen, PSCA

Concentration

0.5 mg/ml

Endotoxin level

Please contact with the lab for this information.

Accession

O43653

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.2% BSA, 0.05% Proclin 300.

Stability and Storage

Store at 4°C for 12 months. Protect from light. Do not freeze.

Clone ID

SAA0474

A facile yeast-display approach for antibody mask discovery., PMID:40381213

Impact of tumor localization on antitumor immunity with conditionally activated CTLA-4 blockade., PMID:40180419

Targeting the tumour cell surface in advanced prostate cancer., PMID:40169837

Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies., PMID:39272956

Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival., PMID:39232121

Discovery of a novel highly specific, fully human PSCA antibody and its application as an antibody-drug conjugate in prostate cancer., PMID:39113562

T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer., PMID:38801069

64Cu tumor labeling with hexadentate picolinic acid-based bispidine immunoconjugates., PMID:38506263

Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer., PMID:37660477

Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer., PMID:37378940

Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer., PMID:37359737

Preclinical Characterization of the 177Lu-Labeled Prostate Stem Cell Antigen (PSCA)-Specific Monoclonal Antibody 7F5., PMID:37298374

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy., PMID:36817127

Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management., PMID:35454902

Targeted Transposition of Minicircle DNA Using Single-Chain Antibody Conjugated Cyclodextrin-Modified Poly (Propylene Imine) Nanocarriers., PMID:35454835

Novel Redirected T-Cell Immunotherapies for Advanced Prostate Cancer., PMID:34675084

Post-transplant Cyclophosphamide Versus Thymoglobulin in HLA-Mismatched Unrelated Donor Transplant for Acute Myelogenous Leukemia and Myelodysplastic Syndrome., PMID:34174469

Targeted RNAi of BIRC5/Survivin Using Antibody-Conjugated Poly(Propylene Imine)-Based Polyplexes Inhibits Growth of PSCA-Positive Tumors., PMID:34066833

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens., PMID:33884106

The Anti-Proliferative Effect of a Newly-Produced Anti-PSCA-Peptide Antibody by Multiple Bioinformatics Tools, on Prostate Cancer Cells., PMID:33176663

Serum total prostate-specific antigen (tPSA): correlation with diagnosis and grading of prostate cancer in core needle biopsy., PMID:32815673

Evaluation of [131I]I- and [177Lu]Lu-DTPA-A11 Minibody for Radioimmunotherapy in a Preclinical Model of PSCA-Expressing Prostate Cancer., PMID:32661830

In Pursuit of Stability Enhancement of a Prostate Cancer Targeting Antibody Derived from a Transgenic Animal Platform., PMID:32546687

Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self., PMID:32451262

Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model., PMID:32016503

Tri-functional platform for construction of modular antibody fragments for in vivo 18F-PET or NIRF molecular imaging., PMID:34123276

Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer., PMID:31839644

In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless., PMID:31380306

[89Zr]A2cDb Immuno-PET of Prostate Cancer in a Human Prostate Stem Cell Antigen Knock-in (hPSCA KI) Syngeneic Model., PMID:31209779

A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for 18F-Immuno-PET and Fluorescence Imaging., PMID:30877181

Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis., PMID:30824859

Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody., PMID:30613270

Quantum dot-based fluorescent probes for targeted imaging of the EJ human bladder urothelial cancer cell line., PMID:30546399

Near-Infrared Dye-Labeled Anti-Prostate Stem Cell Antigen Minibody Enables Real-Time Fluorescence Imaging and Targeted Surgery in Translational Mouse Models., PMID:30301826

Improved Conjugation, 64-Cu Radiolabeling, in Vivo Stability, and Imaging Using Nonprotected Bifunctional Macrocyclic Ligands: Bis(Phosphinate) Cyclam (BPC) Chelators., PMID:30180567

Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody., PMID:29602820

Evaluation of a Pretargeting Strategy for Molecular Imaging of the Prostate Stem Cell Antigen with a Single Chain Antibody., PMID:29491468

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients., PMID:29122836

Formulation of the bivalent prostate cancer vaccine with surgifoam elicits antigen-specific effector T cells in PSA-transgenic mice., PMID:28939158

Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression., PMID:28903367

Atopy and prostate cancer: Is there a link between circulating levels of IgE and PSA in humans?, PMID:28795218

Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer., PMID:28667390

Interaction of the Mineralocorticoid Receptor With RACK1 and Its Role in Aldosterone Signaling., PMID:28472300

Construction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer., PMID:27783810

Engineering A11 Minibody-Conjugated, Polypeptide-Based Gold Nanoshells for Prostate Stem Cell Antigen (PSCA)-Targeted Photothermal Therapy., PMID:27659802

Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time., PMID:26490315

Nanoparticle mediated chemotherapy of hormone refractory prostate cancer with a novel combi-molecule., PMID:26396674

A genome-wide association study for clinical mastitis in first parity US Holstein cows using single-step approach and genomic matrix re-weighting procedure., PMID:25658712

Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer., PMID:25326233

Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells., PMID:25053504

Document Download

Anti-Human PSCA Antibody (SAA0474), FITC.pdf